In conclusion the FCA upheld the Judge's conclusion that the patent claims fail the requirement for product specificity because they do not make specific reference to the medicinal ingredient rilpirivine, but only
the broad class of compounds, but the FCA did so under section 4 (2)(a) rather than 4 (2)(b).
So - called «ivermectin» sensitivity is actually sensitivity to
a broad class of compounds due to a basic defect in the blood - brain barrier.
Not exact matches
Numerous recent articles, including some patent applications, deal with the identification
of compounds belonging to diverse chemical
classes, claiming to inhibit CXCR4, thus, potentially useful for a
broad clinical application.
The diverse range
of polyphenols — a
broad class of health - promoting plant
compounds that includes anthocyanins and ellagic acid — provided by the mix
of berries is likely responsible for the observed benefits.